SCHEMBL29947604

SCHEMBL29947604

N#CC[C@H]1CN(c2nc(Cl)nc3c(F)c(Cl)ncc23)CCN1

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ SCN9A Q15858 1/20 0.31
▸ PRKCQ Q04759 3/20 0.31
▸ PRKCD Q05655 2/20 0.31
▸ HRH4 Q9H3N8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22555268 1.00 SCN9A (0.31) SCN9APRKCQPRKCDHRH4
SCHEMBL22555038 0.90 PRKCQ (0.32) SCN9APRKCQPRKCDHRH4
SCHEMBL22555256 0.88 ERG (0.31) HRH4
SCHEMBL22631412 0.83 SCN9A (0.32) SCN9A
SCHEMBL29235089 0.80 KDM4E (0.33) —
SCHEMBL26947438 0.80 KRAS (0.53) —
SCHEMBL22220231 0.80 KRAS (0.49) —
SCHEMBL22587002 0.80 KRAS (0.35) —
SCHEMBL29947619 0.80 KRAS (0.31) —
SCHEMBL29697734 0.80 SMN1; SMN2 (0.35) PRKCQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022187527-A1 QUINAZOLINE NITRILE DERIVATIVES AS KRAS INHIBITORS NIKANG THERAPEUTICS, INC (US) 2022-09-09 — — WO disclosed
Send feedback